Article PDF :

Veiw Full Text PDF

Article type :

1

Author :

ALI Abd Alkadhim Lafta,Karar Saleem Hussaen,Zubayda Medhat Nouraldean,Haneen Maher Abbas,Layla Ahmed AbdeNabi,Noora Falah Abd Al-Hassan,Elaf serbal lateef

Volume :

2

Issue :

5

Abstract :

Abstract Worldwide, unconjugated hyperbilirubinemia still threatens the health of many newborn infants. Approximately 80% of term newborn infants develop physiologic unconjugated hyperbilirubinemia, which is transient and benign in the vast majority of these infants [1]. A small, but non-negligible proportion may develop severe neonatal hyperbilirubinemia (SNH). An estimated one million newborn infants worldwide suffer from SNH, necessitating intensive treatment to reduce the risk of death or kernicterus spectrum disorders (KSD) [2]. The incidence of SNH varies between 2 and 42 per 100,000 live-born infants in high-income countries (HIC) and depends, at least in part, on the predefined total serum bilirubin (TSB) concentration for this diagnosis